Nakano R, Hata H, Sasaki K, Yamoto M
Br J Obstet Gynaecol. 1980 Apr;87(4):287-91. doi: 10.1111/j.1471-0528.1980.tb04541.x.
A new prostaglandin analogue, 16,16-dimethyl=trans-delta 2-PGE1 methyl ester (16 me E1) was used for preoperative cervical dilatation in 23 pregnant women who had abortion induced for socio-economical reasons in the first trimester of pregnancy. A single vaginal pessary containing 1 mg 16 me E1 was inserted into the posterior fornix at 3-hour intervals. Thirteen (56.5 per cent) of the 23 patients had complete abortions and two patients (8.7 percent) had incomplete abortions. In six patients (26.1 per cent) the cervix was dilated to at least 10 mm and the remaining two patients (8.7 per cent) required mechanical dilatation at the time of vacuum evacuation. Apart from mild gastrointestinal symptoms, no serious side effects were noted. It is concluded that the new prostaglandin analogue, 16 me E1, could be used safely and effectively for preoperative dilatation of the cervix before surgical abortion in early pregnancy.
一种新的前列腺素类似物,16,16 - 二甲基 - 反式 - Δ² - PGE1甲酯(16 - 甲基 - E1)被用于23名因社会经济原因在妊娠早期进行人工流产的孕妇的术前宫颈扩张。每隔3小时将一枚含1毫克16 - 甲基 - E1的阴道栓剂置入后穹窿。23例患者中有13例(56.5%)完全流产,2例患者(8.7%)不全流产。6例患者(26.1%)宫颈扩张至至少10毫米,其余2例患者(8.7%)在真空吸引时需要机械扩张。除了轻微的胃肠道症状外,未观察到严重副作用。结论是,新的前列腺素类似物16 - 甲基 - E1可安全有效地用于早期妊娠手术流产前的宫颈术前扩张。